On the other hand, DPP4i are believed to possess immunomodulatory and other pleiotropic features, potentially improving insulitis and delay β-cell destruction in newly diagnosed persons with T1D who are still able to produce endogenous insulin [108]. The gene discussed is INS; the disease is type 1 diabetes mellitus.